These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


370 related items for PubMed ID: 11007941

  • 21. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC, Lin-Shiau SY, Chen CF, Lin JK.
    J Cell Biochem; 1999 Oct 01; 75(1):1-12. PubMed ID: 10462699
    [Abstract] [Full Text] [Related]

  • 22. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma.
    Nihal M, Ahmad N, Mukhtar H, Wood GS.
    Int J Cancer; 2005 Apr 20; 114(4):513-21. PubMed ID: 15609335
    [Abstract] [Full Text] [Related]

  • 23. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
    Agarwal C, Singh RP, Dhanalakshmi S, Tyagi AK, Tecklenburg M, Sclafani RA, Agarwal R.
    Oncogene; 2003 Nov 13; 22(51):8271-82. PubMed ID: 14614451
    [Abstract] [Full Text] [Related]

  • 24. Prostate cancer prevention by silibinin.
    Singh RP, Agarwal R.
    Curr Cancer Drug Targets; 2004 Feb 13; 4(1):1-11. PubMed ID: 14965263
    [Abstract] [Full Text] [Related]

  • 25. Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes.
    Singh RP, Agarwal C, Agarwal R.
    Carcinogenesis; 2003 Mar 13; 24(3):555-63. PubMed ID: 12663518
    [Abstract] [Full Text] [Related]

  • 26. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate.
    Ahmad N, Cheng P, Mukhtar H.
    Biochem Biophys Res Commun; 2000 Aug 28; 275(2):328-34. PubMed ID: 10964666
    [Abstract] [Full Text] [Related]

  • 27. Anticarcinogenic effect of FTY720 in human prostate carcinoma DU145 cells: modulation of mitogenic signaling, FAK, cell-cycle entry and apoptosis.
    Permpongkosol S, Wang JD, Takahara S, Matsumiya K, Nonomura N, Nishimura K, Tsujimura A, Kongkanand A, Okuyama A.
    Int J Cancer; 2002 Mar 10; 98(2):167-72. PubMed ID: 11857403
    [Abstract] [Full Text] [Related]

  • 28. Chemopreventive potential of epigallocatechin gallate and genistein: evidence from epidemiological and laboratory studies.
    Park OJ, Surh YJ.
    Toxicol Lett; 2004 Apr 15; 150(1):43-56. PubMed ID: 15068824
    [Abstract] [Full Text] [Related]

  • 29. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model.
    Raina K, Blouin MJ, Singh RP, Majeed N, Deep G, Varghese L, Glodé LM, Greenberg NM, Hwang D, Cohen P, Pollak MN, Agarwal R.
    Cancer Res; 2007 Nov 15; 67(22):11083-91. PubMed ID: 18006855
    [Abstract] [Full Text] [Related]

  • 30. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines.
    Masuda M, Suzui M, Weinstein IB.
    Clin Cancer Res; 2001 Dec 15; 7(12):4220-9. PubMed ID: 11751523
    [Abstract] [Full Text] [Related]

  • 31. Antimitogenic effect of green tea (-)-epigallocatechin gallate on 3T3-L1 preadipocytes depends on the ERK and Cdk2 pathways.
    Hung PF, Wu BT, Chen HC, Chen YH, Chen CL, Wu MH, Liu HC, Lee MJ, Kao YH.
    Am J Physiol Cell Physiol; 2005 May 15; 288(5):C1094-108. PubMed ID: 15647388
    [Abstract] [Full Text] [Related]

  • 32. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
    Singh RP, Deep G, Blouin MJ, Pollak MN, Agarwal R.
    Carcinogenesis; 2007 Dec 15; 28(12):2567-74. PubMed ID: 17916909
    [Abstract] [Full Text] [Related]

  • 33. Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer.
    Shankar S, Suthakar G, Srivastava RK.
    Front Biosci; 2007 Sep 01; 12():5039-51. PubMed ID: 17569628
    [Abstract] [Full Text] [Related]

  • 34. Decursin inhibits EGFR-ERK1/2 signaling axis in advanced human prostate carcinoma cells.
    Bhat TA, Dheeraj A, Nambiar DK, Singh SP, Yim DS, Singh RP.
    Prostate; 2023 May 01; 83(6):534-546. PubMed ID: 36597263
    [Abstract] [Full Text] [Related]

  • 35. Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression.
    Ahmad N, Gali H, Javed S, Agarwal R.
    Biochem Biophys Res Commun; 1998 Jun 18; 247(2):294-301. PubMed ID: 9642119
    [Abstract] [Full Text] [Related]

  • 36. Modulation of phosphatidylinositol-3-kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells.
    Siddiqui IA, Adhami VM, Afaq F, Ahmad N, Mukhtar H.
    J Cell Biochem; 2004 Feb 01; 91(2):232-42. PubMed ID: 14743383
    [Abstract] [Full Text] [Related]

  • 37. Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention.
    Zi X, Agarwal R.
    Proc Natl Acad Sci U S A; 1999 Jun 22; 96(13):7490-5. PubMed ID: 10377442
    [Abstract] [Full Text] [Related]

  • 38. Anti-melanoma effects of vorinostat in combination with polyphenolic antioxidant (-)-epigallocatechin-3-gallate (EGCG).
    Nihal M, Roelke CT, Wood GS.
    Pharm Res; 2010 Jun 22; 27(6):1103-14. PubMed ID: 20232120
    [Abstract] [Full Text] [Related]

  • 39. Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells.
    Deep G, Oberlies NH, Kroll DJ, Agarwal R.
    Int J Cancer; 2008 Jul 01; 123(1):41-50. PubMed ID: 18435416
    [Abstract] [Full Text] [Related]

  • 40. Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG.
    Shimizu M, Shirakami Y, Moriwaki H.
    Int J Mol Sci; 2008 Jun 01; 9(6):1034-1049. PubMed ID: 19325845
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.